Micropulse transscleral cyclophotocoagulation results in secondary glaucoma

The aim of this study was to analyze the long-term outcome of first session of micropulse transscleral cyclophotocoagulation (MP-CPC) for refractory glaucoma developed after vitreoretinal surgery combined with silicone oil implantation. The inclusion criteria of this consecutive case series were: patients with secondary glaucoma in the refractory stage who underwent MP-CPC between 2018 and 2021, vitreoretinal surgery combined with silicon oil implantation, and at least a 24-month follow-up period after MP-CPC. Success was defined as the baseline eye pressure reduced at least 20%, and it should be ranged between 10 to 20 mmHg without further MP-CPC at the end of the follow-up. For this retrospective study, 11 eyes of 11 patients were selected. The reduction in IOP was found to be significant (p = 0.004) at the end of the follow-up time, and the success rate was 72% according to our results. The change in the number of antiglaucoma agents in the administered eyedrops was not significant c..., The patients in the study were examined at each visit and the data obtained during the examinations were recorded. Data were collected for a minimum of 24 months for all patients and up to 48 months for some patients. Statistical analysis was performed using IBM SPSS Statistics 25 (SPSS Inc., Chicago, IL, USA), , # Micropulse transscleral cyclophotocoagulation results in secondary glaucoma

DOI: [https://doi.org/10.5061/dryad.v6wwpzh1b](https://doi.org/10.5061/dryad.v6wwpzh1b)

## Description of the Data and file structure

We show 11 patients data. The vertical column shows the number of patients (1 to 11) and the horizontal row shows the variables tested in the different visits. The variables are shown in detail below:

* Age (years)
* Follow-up time (months)
* Number of MP-CPC sessions (MP-CPC: micropulse cyclophotocoagulation)
* Time of 2nd MP-CPC (in months compare4d to the first visit)
* BCVA first (logMAR) (BCVA: best corrected visual acuity; first: at baseline)
* BCVA last (logMAR) (BCVA: best corrected visual acuity; last: at the end of follow-up)
* Ta last (mmHg) (Ta: intraocular pressure, measured with Goldmann applanation tonometry; last: at the end of follow-up)
* 21+20% last (baseline eye pressure should be reduced at least 20% and it should be ranged between 10 to ...